Risk of Depression Associated with Use of Leukotriene Receptor Antagonist in Elderly Asthma Patients in Korea

被引：0
|
作者：
Rhee, Chul Woo [1 ]
Choi, Nam-Kyong [1 ]
Ahn, Yoon-Ok [1 ]
Lee, Joongyub [2 ]
Park, Byung Joo [1 ,2 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
576
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [31] Zafirlukast: The first leukotriene-receptor antagonist approved for the treatment of asthma
    Kelloway, JS
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (09) : 1012 - 1021
  • [32] Focus on zafirlukast: A leukotriene receptor antagonist for the prophylaxis and chronic treatment of asthma
    Baldinger, SL
    Shore, ET
    FORMULARY, 1996, 31 (11) : 1029 - &
  • [33] Leukotriene receptor antagonist may prevent the progression of preschool children asthma
    Ebisawa, M
    Ogata, M
    Komata, T
    Imai, T
    Tomikawa, M
    Shukuya, A
    Tachimoto, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S8 - S8
  • [34] Risk of Neuropsychiatric Diseases According to the Use of a Leukotriene Receptor Antagonist in Middle-Aged and Older Adults with Asthma: A Nationwide Population-Based Study Using Health Claims Data in Korea
    Shim, Ji-Su
    Kim, Min-Hye
    Kim, Min-Ho
    Cho, Young-Joo
    Chun, Eun Mi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4290 - 4297
  • [35] Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression
    Bali, Vishal
    Chatterjee, Satabdi
    Johnson, Michael L.
    Chen, Hua
    Carnahan, Ryan M.
    Aparasu, Rajender R.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (08): : 678 - 686
  • [36] RISK OF DEMENTIA ASSOCIATED WITH THE USE OF PAROXETINE AMONG THE ELDERLY NURSING HOME PATIENTS WITH DEPRESSION
    Bali, V
    Aparasu, R. R.
    Johnson, M. L.
    Chen, H.
    Carnahan, R. M.
    VALUE IN HEALTH, 2014, 17 (03) : A209 - A209
  • [37] Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients
    Tug, T.
    Godekmerdan, A.
    Sari, N.
    Karatas, F.
    Erdem, E. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) : 371 - 376
  • [38] Decreased exhaled nitric oxide in mild persistent asthma patients treated with a leukotriene receptor antagonist, pranlukast
    Kobayashi, H
    Takahashi, Y
    Mitsufuji, H
    Hataishi, R
    Cui, T
    Tanaka, N
    Kawakami, T
    Tomita, T
    JAPANESE JOURNAL OF PHYSIOLOGY, 1999, 49 (06): : 541 - 544
  • [39] Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma
    Yoshihara, Shigemi
    Kikuchi, Yutaka
    Saitou, Mari
    Yanagawa, Susumu
    Kanno, Noriko
    Igarashi, Hiroshi
    Fukuda, Hironobu
    Iimura, Akiko
    Abe, Toshio
    Yamada, Yumi
    Andou, Tamotsu
    Arisaka, Osamu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 3233 - 3238
  • [40] Asthma plus migraine in childhood and adolescence: Prophylactic benefits with leukotriene receptor antagonist
    Carvalho, DD
    Fragoso, YD
    Coelho, FMS
    Pereira, MM
    HEADACHE, 2002, 42 (10): : 1044 - 1047
12345